The Gross Margin of Alnylam Pharmaceuticals Inc (ALNY) is 85.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 85.62% |
| 2023-12-31 | 83.02% |
| 2022-12-31 | 83.73% |
| 2021-12-31 | 83.39% |
| 2020-12-31 | 84.16% |
| 2019-12-31 | 88.58% |
| 2018-12-31 | 97.60% |
| 2017-12-31 | 97.60% |